JNJ

186.14

-0.63%↓

ABT

124.22

-0.81%↓

TMO

567.38

+0.65%↑

ISRG

544.49

+1.43%↑

DHR

212.62

-0.59%↓

JNJ

186.14

-0.63%↓

ABT

124.22

-0.81%↓

TMO

567.38

+0.65%↑

ISRG

544.49

+1.43%↑

DHR

212.62

-0.59%↓

JNJ

186.14

-0.63%↓

ABT

124.22

-0.81%↓

TMO

567.38

+0.65%↑

ISRG

544.49

+1.43%↑

DHR

212.62

-0.59%↓

JNJ

186.14

-0.63%↓

ABT

124.22

-0.81%↓

TMO

567.38

+0.65%↑

ISRG

544.49

+1.43%↑

DHR

212.62

-0.59%↓

JNJ

186.14

-0.63%↓

ABT

124.22

-0.81%↓

TMO

567.38

+0.65%↑

ISRG

544.49

+1.43%↑

DHR

212.62

-0.59%↓

Search

Pluristem Therapeutics Inc

Atidarymo kaina

3.37 -3.99

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.34

Max

3.68

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-10

Pluristem Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-04 23:57; UTC

Uždarbis

Naver's Third-Quarter Earnings Rose on AI Push

2025-11-04 23:10; UTC

Įsigijimai, susijungimai, perėmimai

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

2025-11-04 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

2025-11-04 23:37; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2025-11-04 23:30; UTC

Uždarbis

Itau Unibanco 3Q Net BRL33.7B >ITUB

2025-11-04 23:25; UTC

Uždarbis

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

2025-11-04 23:25; UTC

Uždarbis

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

2025-11-04 23:24; UTC

Uždarbis

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

2025-11-04 23:23; UTC

Uždarbis

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

2025-11-04 23:06; UTC

Uždarbis

Review & Preview: Tech Check -- Barrons.com

2025-11-04 22:52; UTC

Uždarbis

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

2025-11-04 22:33; UTC

Uždarbis

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

2025-11-04 22:29; UTC

Uždarbis

Ashland 4Q Adj EPS $1.08 >ASH

2025-11-04 22:29; UTC

Uždarbis

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

2025-11-04 22:28; UTC

Uždarbis

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

2025-11-04 22:27; UTC

Uždarbis

Ashland 4Q Cont Ops EPS 73c >ASH

2025-11-04 22:27; UTC

Uždarbis

Ashland 4Q EPS 71c >ASH

2025-11-04 22:27; UTC

Uždarbis

Ashland 4Q Sales $478M >ASH

2025-11-04 22:23; UTC

Uždarbis

Ovintiv 3Q EPS 57c >OVV

2025-11-04 22:19; UTC

Rinkos pokalbiai

Canada Budget: Snap Election Talk Might Cool -- Market Talk

2025-11-04 22:16; UTC

Uždarbis

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

2025-11-04 22:14; UTC

Įsigijimai, susijungimai, perėmimai

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

2025-11-04 22:13; UTC

Įsigijimai, susijungimai, perėmimai

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

2025-11-04 22:13; UTC

Įsigijimai, susijungimai, perėmimai

Consortium: Able to Finance a Deal With Available Liquidity

2025-11-04 22:12; UTC

Įsigijimai, susijungimai, perėmimai

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

2025-11-04 22:11; UTC

Uždarbis

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

2025-11-04 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

2025-11-04 22:10; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

2025-11-04 22:07; UTC

Uždarbis

Kinross Gold Raises Dividend to $0.035 >K.T

Akcijų palyginimas

Kainos pokytis

Pluristem Therapeutics Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

$

help-icon Live chat